Systematic Review of Gut Microbiota and Major Depression
Open accessAbstract
Background: Recently discovered relationships between the gastrointestinal microbiome and the brain have implications for psychiatric disorders, including major depressive disorder (MDD). Bacterial transplantation from MDD patients to rodents produces depression-like behaviors. In humans, case-control studies have examined the gut microbiome in healthy and affected individuals. We systematically reviewed existing studies comparing gut microbial composition in MDD and healthy volunteers. Methods: A PubMed literature search combined the terms “depression,” “depressive disorder,” “stool,” “fecal,” “gut,” and “microbiome” to identify human case-control studies that investigated relationships between MDD and microbiota quantified from stool. We evaluated the resulting studies, focusing on bacterial taxa that were different between MDD and healthy controls. Results: Six eligible studies were found in which 50 taxa exhibited differences (p<0.05) between patients with MDD and controls. Patient characteristics and methodologies varied widely between studies. Five phyla—Bacteroidetes, Firmicutes, Actinobacteria, Fusobacteria and Protobacteria—were represented; however, divergent results occurred across studies for all phyla. The largest number of differentiating taxa were within phylum Firmicutes, in which nine families and twelve genera differentiated the diagnostic groups. The majority of these families and genera were found to be statistically different between the two groups in two studies identified. Family Lachnospiraceae differentiated the diagnostic groups in four studies (with an even split in directionality). Across all five phyla, nine genera were higher in MDD (Anaerostipes, Blautia, Clostridium, Klebsiella, Lachnospiraceae incertae sedis, Parabacteroides, Parasuterella, Phascolarctobacterium, and Streptococcus), six were lower (Bifidobacterium, Dialister, Escherichia/Shigella, Faecalibacterium, and Ruminococcus), and six were divergent (Alistipes, Bacteroides, Megamonas, Oscillibacter, Prevotella, and Roseburia). We highlight mechanisms and products of bacterial metabolism as they may relate to the etiology of depression. Conclusions: No consensus has emerged from existing human studies of depression and gut microbiome concerning which bacterial taxa are most relevant to depression. This may in part be due to differences in study design. Given that bacterial functions are conserved across taxonomic groups, we propose that studying microbial functioning may be more productive than a purely taxonomic approach to understanding the gut microbiome in depression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These taxa may interface with conserved aspects of mammalian neurophysiology.
“These associations also exist in human clinical populations—for example, members of the Lachnospiraceae are frequently associated with diagnoses of major depressive disorder across studies60–63—suggesting that these taxa may interface with conserved aspects of mammalian neurophysiology.”
From Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in AppNL-G-F, AppNL-F, and wild type mice (2021) · cites this paper as [62]
Members of the Lachnospiraceae are frequently associated with diagnoses of major depressive disorder across studies.
“These associations also exist in human clinical populations—for example, members of the Lachnospiraceae are frequently associated with diagnoses of major depressive disorder across studies60–63—suggesting that these taxa may interface with conserved aspects of mammalian neurophysiology.”
From Integrated analysis of behavioral, epigenetic, and gut microbiome analyses in AppNL-G-F, AppNL-F, and wild type mice (2021) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · see citing works
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 4× · see citing works
“Depression severity was assessed variously by the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HAM).”
MethodInfluentialA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · see citing works
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · see citing works
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · see citing works
Population-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · see citing works
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256 · see citing works
Shotgun metagenomics, from sampling to analysis
Quince, C., Walker, A. W., Simpson, J. T., Loman, N. J., & Segata, N. (2017) · Nature Biotechnology · doi:10.1038/nbt.3935 · Cited by 2,202 · see citing works
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893 · see citing works
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · see citing works
American Gut: an Open Platform for Citizen-Science Microbiome Research
McDonalda, D., Hyde, E., Debelius, J. W., Morton, J. T., Gonzalez, A., Ackermann, G., Aksenov, A. A., Behsaz, B., Brennan, C., Chen, Y., et al. (2018) · doi:10.1101/277970 · Cited by 878 · see citing works
Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., Kenis, G., Bosmans, E., De Meester, I., Benoy, I., Neels, H., et al. (1998) · Cytokine · doi:10.1006/cyto.1997.0290 · Cited by 772 · see citing works
The neurobiology of depression: An integrated view
Dean, J., & Keshavan, M. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.025 · Cited by 765 · cited 3× · see citing works
“Despite significant advances in our understanding of the etiology of MDD (4), existing knowledge is incomplete, treatments are inadequate, and new insights into MDD pathophysiology are urgently needed.”
BackgroundYoshioka, H., Iseki, K.-I., & Fujita, K. (1983) · PEDIATRICS · doi:10.1542/peds.72.3.317 · Cited by 516 · see citing works
Schauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383 · see citing works
Guida, F., Turco, F., Iannotta, M., De Gregorio, D., Palumbo, I., Sarnelli, G., Furiano, A., Napolitano, F., Boccella, S., Luongo, L., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.001 · Cited by 367 · see citing works
Swidsinski, A. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1131 · Cited by 314 · see citing works
Liu, W.-H., Chuang, H.-L., Huang, Y.-T., Wu, C.-C., Chou, G.-T., Wang, S., & Tsai, Y.-C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.046 · Cited by 269 · see citing works
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G., & Ellingrod, V. L. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1890 · Cited by 235 · cited 1× · see citing works
“In a study of bipolar adults (38), significant changes in the abundance of three genera were identified between those taking vs.”
BackgroundA broken promise: microbiome differential abundance methods do not control the false discovery rate
Hawinkel, S., Mattiello, F., Bijnens, L., & Thas, O. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx104 · Cited by 199 · see citing works
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
Morgan, A. P., Crowley, J. J., Nonneman, R. J., Quackenbush, C. R., Miller, C. N., Ryan, A. K., Bogue, M. A., Paredes, S. H., Yourstone, S., Carroll, I. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115225 · Cited by 197 · see citing works
Gut microbiota interacts with brain microstructure and function
Fernandez-Real, J.-M., Serino, M., Blasco, G., Puig, J., Daunis-i-Estadella, J., Ricart, W., Burcelin, R., Fernández-Aranda, F., & Portero-Otin, M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3076 · Cited by 167 · see citing works
Bahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143 · see citing works
Use of dietary indices to control for diet in human gut microbiota studies
Bowyer, R. C. E., Jackson, M. A., Pallister, T., Skinner, J., Spector, T. D., Welch, A. A., & Steves, C. J. (2018) · Microbiome · doi:10.1186/s40168-018-0455-y · Cited by 140 · see citing works
Bhandari, S., Larson, M. E., Kumar, N., & Stein, D. (2017) · Gut and Liver · doi:10.5009/gnl16347 · Cited by 66 · see citing works
Flagged first, then by citations
Research works printed but not linked: 124
- [1]Gotlib IH Hammen CL Handbook of Depression. New York, NY: The Guilford Press (2009).
- [6]Tannock GW Understanding the Gut Microbiota. Hoboken, NJ: John Wiley & Sons (2017). 10.1002/9781118801413 · DOI
- [8]Ait-Belgnaoui A Durand H Cartier C Chaumaz G Eutamene H Ferrier L. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology (2012) 37: 1885– 95. 10.1016/j.psyneuen.2012.03.024 22541937 · DOI · Paper page
- [9]Barrett E Ross RP O'Toole PW Fitzgerald GF Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol. (2012) 113: 411– 7. 10.1111/j.1365-2672.2012.05344.x 22612585 · DOI · Paper page
- [10]Cummings JH Pomare EW Branch WJ Naylor CP Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut (1987) 28: 1221– 7. 10.1136/gut.28.10.1221 3678950 PMC1433442 · DOI · Paper page
- [11]Hooper LV Stappenbeck TS Hong CV Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. (2003) 4: 269– 73. 10.1038/ni888 12548285 · DOI
- [13]Cash HL Whitham CV Behrendt CL Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 313: 1126– 30. 10.1126/science.1127119 16931762 PMC2716667 · DOI · Paper page
- [14]Bouskra D Brézillon C Bérard M Werts C Varona R Boneca IG. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature (2008) 456: 507. 10.1038/nature07450 18987631 · DOI · Paper page
- [16]Miyamoto J Mizukure T Park SB Kishino S Kimura I Hirano K. A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem. (2015) 290: 2902– 18. 10.1074/jbc.M114.610733 25505251 PMC4317025 · DOI · Paper page
- [17]Maes M Kubera M Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria, (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. (2008) 29: 117– 24. 18283240
- [18]Maes M Kubera M Leunis JC Berk M Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. (2012) 141: 55– 62. 10.1016/j.jad.2012.02.023 22410503 · DOI · Paper page
- [19]Maes M Kubera M Leunis JC Berk M Geffard M Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress, (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand. (2013) 127: 344– 54. 10.1111/j.1600-0447.2012.01908.x 22900942 · DOI
- [22]Kelly JR Borre Y O'Brien C Patterson E El Aidy S Deane J. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. (2016) 82: 109– 18. 10.1016/j.jpsychires.2016.07.019 27491067 · DOI · Paper page
- [23]Zheng P Zeng B Zhou C Liu M Fang Z Xu X. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Mol Psychiatry (2016) 21: 786– 96. 10.1038/mp.2016.44 27067014 · DOI · Paper page
- [24]Mi GL Zhao L Qiao DD Kang WQ Tang MQ Xu JK. Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie van Leeuwenhoek (2015) 107: 1547– 53. 10.1007/s10482-015-0448-9 25876529 · DOI
- [25]Hsiao EY Sara McBride W Hsien S Sharon G Embriette Hyde R McCue T. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 155: 1451– 63. 10.1016/j.cell.2013.11.024 24315484 PMC3897394 · DOI · Paper page
- [26]Naseribafrouei A Hestad K Avershina E Sekelja M Linlokken A Wilson R. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil (2014) 26: 1155– 62. 10.1111/nmo.12378 24888394 · DOI · Paper page
- [27]Jiang H Ling Z Zhang Y Mao H Ma Z Yin Y. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. (2015) 48: 186– 94. 10.1016/j.bbi.2015.03.016 25882912 · DOI · Paper page
- [28]Aizawa E Tsuji H Asahara T Takahashi T Teraishi T Yoshida S. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord. (2016) 202: 254– 7. 10.1016/j.jad.2016.05.038 27288567 · DOI · Paper page
- [29]Lin P Ding B Feng C Yin S Zhang T Qi X. Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder. J Affect Disord. (2017) 207: 300– 4. 10.1016/j.jad.2016.09.051 27741466 · DOI · Paper page
- [30]Chen Z Li J Gui S Zhou C Chen J Yang C. Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder. Neuroreport (2018) 29: 417– 25. 10.1097/WNR.0000000000000985 29432299 · DOI
- [32]Wu GD Chen J Hoffmann C Bittinger K Chen YY Keilbaugh SA. Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 334: 105– 8. 10.1126/science.1208344 21885731 PMC3368382 · DOI · Paper page
- [34]He Y Wu W Zheng HM Li P McDonald D Sheng HF Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med. (2018) 24: 1532– 5. 10.1038/s41591-018-0164-x 30150716 · DOI · Paper page
- [35]Davey KJ Cotter PD O'Sullivan O Crispie F Dinan TG Cryan JF. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry (2013) 3: e309. 10.1038/tp.2013.83 24084940 PMC3818006 · DOI · Paper page
- [39]Thomas CM Versalovic J. Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes (2010) 1: 148– 63. 10.4161/gmic.1.3.11712 20672012 PMC2909492 · DOI
- [40]Hemarajata P Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. (2013) 6: 39– 51. 10.1177/1756283X12459294 23320049 PMC3539293 · DOI · Paper page
- [42]Spencer MD Hamp TJ Reid RW Fischer LM Zeisel SH Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology (2011) 140: 976– 86. 10.1053/j.gastro.2010.11.049 21129376 PMC3049827 · DOI · Paper page
- [43]Huttenhower C Structure, function and diversity of the healthy human microbiome. Nature (2012) 486: 207– 14. 10.1038/nature11234 22699609 PMC3564958 · DOI · Paper page
- [44]Yadav M Verma MK Chauhan NS. A review of metabolic potential of human gut microbiome in human nutrition. Arch Microbiol. (2018) 200: 203– 17. 10.1007/s00203-017-1459-x 29188341 · DOI
- [45]Kamada N Chen GY Inohara N Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. (2013) 14: 685– 90. 10.1038/ni.2608 23778796 PMC4083503 · DOI · Paper page
- [46]Lyte M. Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathogens (2013) 9: e1003726. 10.1371/journal.ppat.1003726 24244158 PMC3828163 · DOI · Paper page
- [47]Turnbaugh PJ Hamady M Yatsunenko T Cantarel BL Duncan A Ley RE. A core gut microbiome in obese and lean twins. Nature (2009) 457: 480– 4. 10.1038/nature07540 19043404 PMC2677729 · DOI · Paper page
- [48]Haghikia A Jorg S Duscha A Berg J Manzel A Waschbisch A. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity (2015) 43: 817– 29. 10.1016/j.immuni.2015.09.007 26488817 · DOI · Paper page
- [49]Koh A De Vadder F Kovatcheva-Datchary P Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell (2016) 165: 1332– 45. 10.1016/j.cell.2016.05.041 27259147 · DOI · Paper page
- [50]Zimmerman MA Singh N Martin PM Thangaraju M Ganapathy V Waller JL. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol. (2012) 302: G1405– 15. 10.1152/ajpgi.00543.2011 22517765 PMC3378095 · DOI
- [52]Singh N. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity (2014) 40: 128– 39. 10.1016/j.immuni.2013.12.007 24412617 PMC4305274 · DOI · Paper page
- [53]Fuchikami M Yamamoto S Morinobu S Okada S Yamawaki Y Yamawaki S. The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry (2016) 64: 320– 4. 10.1016/j.pnpbp.2015.03.010 25818247 · DOI
- [54]DeCastro M Nankova BB Shah P Patel P Mally PV Mishra R. Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Mol Brain Res. (2005) 142: 28– 38. 10.1016/j.molbrainres.2005.09.002 16219387 · DOI · Paper page
- [55]Wu X Chen PS Dallas S Wilson B Block ML Wang CC. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol. (2008) 11: 1123– 34. 10.1017/S1461145708009024 18611290 PMC2579941 · DOI
- [56]Kidd SK Schneider JS. Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Brain Res. (2010) 1354: 172– 8. 10.1016/j.brainres.2010.07.041 20654591 PMC2941155 · DOI · Paper page
- [57]Wall R Cryan JF Ross RP Fitzgerald GF Dinan TG Stanton C. Bacterial neuroactive compounds produced by psychobiotics. In: Lyte M Cryan JF editors. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. New York, NY: Springer New York (2014). p. 221– 39. 24997036
- [58]Sheydina A Eberhardt RY Rigden DJ Chang Y Li Z Zmasek CC. Structural genomics analysis of uncharacterized protein families overrepresented in human gut bacteria identifies a novel glycoside hydrolase. BMC Bioinformatics (2014) 15: 112. 10.1186/1471-2105-15-112 24742328 PMC4032388 · DOI
- [59]Duranti S Milani C Lugli GA Turroni F Mancabelli L Sanchez B. Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum. Environ Microbiol. (2015) 17: 2515– 31. 10.1111/1462-2920.12743 25523018 · DOI
- [60]Liu S Ren F Zhao L Jiang L Hao Y Jin J. Starch and starch hydrolysates are favorable carbon sources for bifidobacteria in the human gut. BMC Microbiol. (2015) 15: 54. 10.1186/s12866-015-0362-3 25887661 PMC4349234 · DOI
- [61]Khoroshkin MS Leyn SA Van Sinderen D Rodionov DA. Transcriptional regulation of carbohydrate utilization pathways in the bifidobacterium genus. Front Microbiol. (2016) 7: 120. 10.3389/fmicb.2016.00120 26903998 PMC4746261 · DOI
- [62]Ozcan E Sun J Rowley DC Sela DA. A human gut commensal ferments cranberry carbohydrates to produce formate. Appl Environ Microbiol. (2017) [Epub ahead of print]. 10.1128/AEM.01097-17 28667113 PMC5561279 · DOI
- [63]Chung WSF Meijerink M Zeuner B Holck J Louis P Meyer AS. Prebiotic potential of pectin and pectic oligosaccharides to promote anti-inflammatory commensal bacteria in the human colon. FEMS Microbiol Ecol. (2017) 93:. 10.1093/femsec/fix127 29029078 · DOI
- [64]Tan K Tesar C Wilton R Keigher L Babnigg G Joachimiak A. Novel alpha-glucosidase from human gut microbiome: substrate specificities and their switch. FASEB J (2010) 24: 3939– 49. 10.1096/fj.10-156257 20581222 PMC2996916 · DOI
- [65]Mao B Li D Zhao J Liu X Gu Z Chen YQ. In vitro fermentation of fructooligosaccharides with human gut bacteria. Food Funct. (2015) 6: 947– 54. 10.1039/C4FO01082E 25653214 · DOI
- [66]Morais S Ben David Y Bensoussan L Duncan SH Koropatkin NM Martens EC. Enzymatic profiling of cellulosomal enzymes from the human gut bacterium, Ruminococcus champanellensis, reveals a fine-tuned system for cohesin-dockerin recognition. Environ Microbiol. (2016) 18: 542– 56. 10.1111/1462-2920.13047 26347002 · DOI
- [67]Hehemann JH Kelly AG Pudlo NA Martens EC Boraston AB. Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes. Proc Natl Acad Sci USA. (2012) 109: 19786– 91. 10.1073/pnas.1211002109 23150581 PMC3511707 · DOI · Paper page
- [68]Zhang M Chekan JR Dodd D Hong PY Radlinski L Revindran V. Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. Proc Natl Acad Sci USA. (2014) 111: E3708– 17. 10.1073/pnas.1406156111 25136124 PMC4156774 · DOI
- [69]Pudlo NA Urs K Kumar SS German JB Mills DA Martens EC. Symbiotic human gut bacteria with variable metabolic priorities for host mucosal glycans. MBio (2015) 6: e01282– 15. 10.1128/mBio.01282-15 26556271 PMC4659458 · DOI · Paper page
- [70]Despres J Forano E Lepercq P Comtet-Marre S Jubelin G Yeoman CJ Unraveling the pectinolytic function of Bacteroides xylanisolvens using a RNA-seq approach and mutagenesis. BMC Genomics (2016) 17: 147 10.1186/s12864-016-2472-1 26920945 PMC4769552 · DOI
- [71]Rakoff-Nahoum S Foster KR Comstock LE. The evolution of cooperation within the gut microbiota. Nature (2016) 533: 255– 9. 10.1038/nature17626 27111508 PMC4978124 · DOI · Paper page
- [72]Tauzin AS Kwiatkowski KJ Orlovsky NI Smith CJ Creagh AL Haynes CA. Molecular dissection of xyloglucan recognition in a prominent human gut symbiont. MBio (2016) 7: e02134– 15. 10.1128/mBio.02134-15 27118585 PMC4850273 · DOI
- [73]Tauzin AS Laville E Xiao Y Nouaille S Le Bourgeois P Heux S. Functional characterization of a gene locus from an uncultured gut Bacteroides conferring xylo-oligosaccharides utilization to Escherichia coli. Mol Microbiol. (2016) 102: 579– 92. 10.1111/mmi.13480 27573446 · DOI
- [74]Ali-Ahmad A Garron ML Zamboni V Lenfant N Nurizzo D Henrissat B. Structural insights into a family 39 glycoside hydrolase from the gut symbiont Bacteroides cellulosilyticus WH2. J Struct Biol. (2017) 197: 227– 35. 10.1016/j.jsb.2016.11.004 27890857 · DOI
- [75]Costliow ZA Degnan PH. Thiamine acquisition strategies impact metabolism and competition in the gut microbe bacteroides thetaiotaomicron. mSystems (2017) 2: e00116– 17. 10.1128/mSystems.00116-17 28951891 PMC5613172 · DOI
- [76]Ndeh D Rogowski A Cartmell A Luis AS Basle A Gray J. Complex pectin metabolism by gut bacteria reveals novel catalytic functions. Nature (2017) 544: 65– 70. 10.1038/nature21725 28329766 PMC5388186 · DOI
- [77]Temple MJ Cuskin F Basle A Hickey N Speciale G Williams SJ. A Bacteroidetes locus dedicated to fungal 1,6-beta-glucan degradation: unique substrate conformation drives specificity of the key endo-1,6-beta-glucanase. J Biol Chem. (2017) 292: 10639– 50. 10.1074/jbc.M117.787606 28461332 PMC5481569 · DOI
- [78]Praharaj AB Dehury B Mahapatra N Kar SK Behera SK. Molecular dynamics insights into the structure, function, and substrate binding mechanism of mucin desulfating sulfatase of gut microbe Bacteroides fragilis. J Cell Biochem. (2018) 119: 3618– 31. 10.1002/jcb.26569 29232003 · DOI
- [79]Sato T Kusuhara S Yokoi W Ito M Miyazaki K. Prebiotic potential of L-sorbose and xylitol in promoting the growth and metabolic activity of specific butyrate-producing bacteria in human fecal culture. FEMS Microbiol Ecol. (2017) 93: fiw227. 10.1093/femsec/fiw227 27810878 · DOI
- [80]Plichta DR Juncker AS Bertalan M Rettedal E Gautier L Varela E. Transcriptional interactions suggest niche segregation among microorganisms in the human gut. Nat Microbiol. (2016) 1: 16152. 10.1038/nmicrobiol.2016.152 27564131 · DOI
- [81]Van den Abbeele P Belzer C Goossens M Kleerebezem M De Vos WM Thas O. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J (2013) 7: 949– 61. 10.1038/ismej.2012.158 23235287 PMC3635240 · DOI
- [82]Grondin JM Duan D Kirlin AC Abe KT Chitayat S Spencer HL. Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from Clostridium perfringens. PLoS ONE (2017) 12: e0171606. 10.1371/journal.pone.0171606 28158290 PMC5291390 · DOI
- [83]Caminero A Herran AR Nistal E Perez-Andres J Vaquero L Vivas S. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. (2014) 88: 309– 19. 10.1111/1574-6941.12295 24499426 · DOI
- [84]Kaur H Das C Mande SS. In silico analysis of putrefaction pathways in bacteria and its implication in colorectal cancer. Front Microbiol. (2017) 8: 2166. 10.3389/fmicb.2017.02166 29163445 PMC5682003 · DOI
- [85]McLuskey K Grewal JS Das D Godzik A Lesley SA Deacon AM. Crystal structure and activity studies of the C11 cysteine peptidase from parabacteroides merdae in the human gut microbiome. J Biol Chem. (2016) 291: 9482– 91. 10.1074/jbc.M115.706143 26940874 PMC4850288 · DOI
- [86]Sanctuary MR Kain JN Angkustsiri K German JB. Dietary considerations in autism spectrum disorders: the potential role of protein digestion and microbial putrefaction in the gut-brain axis. Front Nutr. (2018) 5: 40. 10.3389/fnut.2018.00040 29868601 PMC5968124 · DOI
- [87]Wolfe AR Arroyo C Tedders SH Li Y Dai Q Zhang J. Dietary protein and protein-rich food in relation to severely depressed mood: A 10 year follow-up of a national cohort. Prog Neuropsychopharmacol Biol Psychiatry (2011) 35: 232– 8. 10.1016/j.pnpbp.2010.11.011 21108982 · DOI
- [88]Pooyan S Rahimi MH Mollahosseini M Khorrami-Nezhad L Nasir Y Maghbooli Z. A high-protein/low-fat diet may interact with vitamin D-binding protein gene variants to moderate the risk of depression in apparently healthy adults. Lifestyle Genom. (2018) 11: 64– 72. 10.1159/000492497 30184533 · DOI
- [90]Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J. (2011) 437: 357– 72. 10.1042/BJ20110326 21749321 PMC4049159 · DOI
- [91]Kwak MJ Kwon SK Yoon JK Song JY Seo JG Chung MJ. Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function. Syst Appl Microbiol. (2016) 39: 429– 39. 10.1016/j.syapm.2016.07.004 27524178 · DOI
- [92]Gilbody S Lightfoot T Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health (2007) 61: 631– 7. 10.1136/jech.2006.050385 17568057 PMC2465760 · DOI
- [93]Beydoun MA Shroff MR Beydoun HA Zonderman AB. Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosom Med. (2010) 72: 862– 73. 10.1097/PSY.0b013e3181f61863 20841559 PMC2978275 · DOI
- [94]Kumar CK Moyer MP Dudeja PK Said HM. A protein-tyrosine kinase-regulated, pH-dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460. J Biol Chem. (1997) 272: 6226– 31. 10.1074/jbc.272.10.6226 9045638 · DOI
- [95]Dudeja PK Torania SA Said HM. Evidence for the existence of a carrier-mediated folate uptake mechanism in human colonic luminal membranes. Am J Physiol. (1997) 272(6 Pt 1): G1408– 15. 9227476
- [96]Zhang G Ding H Chen H Ye X Li H Lin X. Thiamine nutritional status and depressive symptoms are inversely associated among older Chinese adults. J Nutr. (2013) 143: 53– 8. 10.3945/jn.112.167007 23173173 PMC3521461 · DOI
- [97]Said HM. Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu Rev Physiol. (2004) 66: 419– 46. 10.1146/annurev.physiol.66.032102.144611 14977409 · DOI
- [98]Paerl RW Bertrand EM Rowland E Schatt P Mehiri M Niehaus TD Carboxythiazole is a key microbial nutrient currency and critical component of thiamin biosynthesis. Sci Rep. (2018) 8: 5940 10.1038/s41598-018-24321-2 29654239 PMC5899164 · DOI
- [99]Pinto-Sanchez MI Ford AC Avila CA Verdu EF Collins SM Morgan D. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol. (2015) 110: 1038. 10.1038/ajg.2015.128 25964226 · DOI
- [101]Vivinus-Nebot M Dainese R Anty R Saint-Paul MC Nano JL Gonthier N. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol. (2012) 107: 75– 81. 10.1038/ajg.2011.315 21931380 · DOI
- [103]Ye D Ma I Ma TY. Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier. Am J Physiol. (2006) 290: G496– 504. 10.1152/ajpgi.00318.2005 16474009 · DOI
- [104]Bischoff SC Barbara G Buurman W Ockhuizen T Schulzke JD Serino M. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. (2014) 14: 189. 10.1186/s12876-014-0189-7 25407511 PMC4253991 · DOI · Paper page
- [105]Wei EP Ellison MD Kontos HA Povlishock JT. O2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am J Physiol. (1986) 251(4 Pt 2): H693– 99. 3094386
- [106]Easton AS Fraser PA. Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat. J Physiol. (1998) 507(Pt 2): 541– 7. 9518711 PMC2230805
- [107]Marchiando AM Shen L Graham WV Edelblum KL Duckworth CA Guan Y. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology (2011) 140: 1208– 18.e1– 2. 10.1053/j.gastro.2011.01.004 21237166 PMC3066304 · DOI
- [109]Miura H Ozaki N Sawada M Isobe K Ohta T Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress (2008) 11: 198– 209. 10.1080/10253890701754068 18465467 · DOI · Paper page
- [110]Schwarcz R Whetsell WO Jr Mangano RM. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 219: 316– 8. 10.1126/science.6849138 6849138 · DOI
- [111]Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J (2012) 279: 1356– 65. 10.1111/j.1742-4658.2012.08485.x 22248144 · DOI · Paper page
- [112]Williams BB Van Benschoten Andrew H Cimermancic P Donia MS Zimmermann M Taketani M. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe (2014) 16: 495– 503. 10.1016/j.chom.2014.09.001 25263219 PMC4260654 · DOI · Paper page
- [113]Yunes RA Poluektova EU Dyachkova MS Klimina KM Kovtun AS Averina OV. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe (2016) 42: 197– 204. 10.1016/j.anaerobe.2016.10.011 27794467 · DOI
- [114]O'Mahony SM Clarke G Borre YE Dinan TG Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. (2015) 277: 32– 48. 10.1016/j.bbr.2014.07.027 25078296 · DOI · Paper page
- [116]Bercik P Park AJ Sinclair D Khoshdel A Lu J Huang X. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterol Motil. (2011) 23: 1132– 9. 10.1111/j.1365-2982.2011.01796.x 21988661 PMC3413724 · DOI · Paper page
- [117]Bravo JA Forsythe P Chew MV Escaravage E Savignac HM Dinan TG. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. (2011) 108: 16050– 5. 10.1073/pnas.1102999108 21876150 PMC3179073 · DOI · Paper page
- [119]Tillisch K Mayer E Gupta A Gill Z Brazeilles R Le Neve B. Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women. Psychosom Med. (2017) 79: 905– 13. 10.1097/PSY.0000000000000493 28661940 PMC6089374 · DOI · Paper page
- [120]Tillisch K Labus J Kilpatrick L Jiang Z Stains J Ebrat B. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 144: 1394– 401. 1401.e1391–4. 10.1053/j.gastro.2013.02.043 23474283 PMC3839572 · DOI · Paper page
- [121]Pinto-Sanchez MI Hall GB Ghajar K Nardelli A Bolino C Lau JT. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology (2017) 153: 448– 59.e8. 10.1053/j.gastro.2017.05.003 28483500 · DOI · Paper page
- [123]Lin PY Huang SY Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry (2010) 68: 140– 7. 10.1016/j.biopsych.2010.03.018 20452573 · DOI · Paper page
- [124]Liu JJ Green P John Mann J Rapoport SI Sublette ME. Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res. (2015) 1597: 220– 46. 10.1016/j.brainres.2014.11.059 25498862 PMC4339314 · DOI
- [125]Kankaanpää PE Salminen SJ Isolauri E Lee YK. The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett. (2001) 194: 149– 53. 10.1111/j.1574-6968.2001.tb09460.x 11164299 · DOI
- [126]Bomba A Nemcova R Gancarcikova S Herich R Guba P Mudronova D. Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr. (2002) 88(Suppl. 1): S95– 9. 10.1079/BJN2002634 12215187 · DOI
- [127]Ohtsuka Y Yamashiro Y Shimizu T Nagata S Igarashi J Shinohara K. Reducing cell membrane n-6 fatty acids attenuate mucosal damage in food-sensitive enteropathy in mice. Pediatr Res. (1997) 42: 835– 9. 10.1203/00006450-199712000-00019 9396566 · DOI
- [128]Druart C Dewulf EM Cani PD Neyrinck AM Thissen JP Delzenne NM. Gut microbial metabolites of polyunsaturated fatty acids correlate with specific fecal bacteria and serum markers of metabolic syndrome in obese women. Lipids (2014) 49: 397– 402. 10.1007/s11745-014-3881-z 24473752 · DOI
- [129]Raimondi S Amaretti A Leonardi A Quartieri A Gozzoli C Rossi M. Conjugated linoleic acid production by bifidobacteria: screening, kinetic, and composition. Biomed Res Int. (2016) 2016: 8654317. 10.1155/2016/8654317 27429985 PMC4939342 · DOI
- [130]Kim W Kim H Lee S Current state and applications of microbial genome-scale metabolic models. Curr Opin Syst Biol. (2017) 2: 10– 8. 10.1016/j.coisb.2017.03.001 · DOI
- [131]Bordbar A Monk JM King ZA Palsson BO. Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet. (2014) 15: 107– 20. 10.1038/nrg3643 24430943 · DOI
- [132]McCloskey D Palsson BO Feist AM. Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli. Mol Syst Biol. (2013) 9: 661. 10.1038/msb.2013.18 23632383 PMC3658273 · DOI
- [134]Korem T Zeevi D Suez J Weinberger A Avnit-Sagi T Pompan-Lotan M. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples. Science (2015) 349: 1101– 6. 10.1126/science.aac4812 26229116 PMC5087275 · DOI
- [135]Maier L Pruteanu M Kuhn M Zeller G Telzerow A Anderson EE. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature (2018) 555: 623– 8. 10.1038/nature25979 29555994 PMC6108420 · DOI · Paper page
- [136]Cueva C Gil-Sanchez I Ayuda-Duran B Gonzalez-Manzano S Gonzalez-Paramas AM Santos-Buelga C. An integrated view of the effects of wine polyphenols and their relevant metabolites on gut and host health. Molecules (2017) 22: E99. 10.3390/molecules22010099 28067835 PMC6155716 · DOI
- [138]Zhernakova A Kurilshikov A Bonder MJ Tigchelaar EF Schirmer M Vatanen T. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (2016) 352: 565– 9. 10.1126/science.aad3369 27126040 PMC5240844 · DOI · Paper page
- [139]Turner TN Sharma K Oh EC Liu YP Collins RL Sosa MX. Loss of δ-catenin function in severe autism. Nature (2015) 520: 51– 6. 10.1038/nature14186 25807484 PMC4383723 · DOI
- [140]Pullabhatla V Roberts AL Lewis MJ Mauro D Morris DL Odhams CA. De novo mutations implicate novel genes in systemic lupus erythematosus. Hum Mol Genet. (2018) 27: 421– 9. 10.1093/hmg/ddx407 29177435 PMC5886157 · DOI
- [141]Shankar J. Insights into study design and statistical analyses in translational microbiome studies. Ann Transl Med. (2017) 5: 249. 10.21037/atm.2017.01.13 28706917 PMC5497086 · DOI
- [144]Guenther PM Casavale KO Reedy J Kirkpatrick SI Hiza HA Kuczynski KJ. Update of the healthy eating index: HEI-2010. J Acad Nutr Diet (2013) 113: 569– 80. 10.1016/j.jand.2012.12.016 23415502 PMC3810369 · DOI
- [146]Cenit MC Sanz Y Codoner-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol. (2017) 23: 5486– 98. 10.3748/wjg.v23.i30.5486 28852308 PMC5558112 · DOI
- [147]Vuong HE Hsiao EY. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry (2017) 81: 411– 23. 10.1016/j.biopsych.2016.08.024 27773355 PMC5285286 · DOI · Paper page
- [148]Nguyen TT Kosciolek T Eyler LT Knight R Jeste DV. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res. (2018) 99: 50– 61. 10.1016/j.jpsychires.2018.01.013 29407287 PMC5849533 · DOI
- [150]Nani BD Lima PO Marcondes FK Groppo FC Rolim GS Moraes AB. Changes in salivary microbiota increase volatile sulfur compounds production in healthy male subjects with academic-related chronic stress. PLoS ONE (2017) 12: e0173686. 10.1371/journal.pone.0173686 28319129 PMC5358872 · DOI
- [151]Lamb AL Hess DE Edenborn S Ubinger E Carrillo AE Appasamy PM. Elevated salivary IgA, decreased anxiety, and an altered oral microbiota are associated with active participation on an undergraduate athletic team. Physiol Behav. (2017) 169: 169– 77. 10.1016/j.physbeh.2016.12.004 27932242 · DOI
- [152]Qiao Y Wu M Feng Y Zhou Z Chen L Chen F. Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls. Sci Rep. (2018) 8: 1597. 10.1038/s41598-018-19982-y 29371629 PMC5785483 · DOI
- [153]Gonzalez A Hyde E Sangwan N Gilbert JA Viirre E Knight R. Migraines are correlated with higher levels of Nitrate-, Nitrite-, and Nitric Oxide-reducing oral microbes in the american gut project cohort. mSystems (2016) 1: 1– 4. 10.1128/mSystems.00105-16 27822557 PMC5080405 · DOI
Cited by
Sorted by citations
The gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912 · see citing works
López-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499 · see citing works
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502 · see citing works
Gut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.102 · Cited by 372 · see citing works
The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?
Misiak, B., Łoniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109951 · Cited by 343 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Firth, J., Teasdale, S. B., Allott, K., Siskind, D., Marx, W., Cotter, J., Veronese, N., Schuch, F., Smith, L., Solmi, M., et al. (2019) · World Psychiatry · doi:10.1002/wps.20672 · Cited by 214 · see citing works
Liu, C.-H., Yang, M.-H., Zhang, G.-Z., Wang, X.-X., Li, B., Li, M., Woelfer, M., Walter, M., & Wang, L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01732-5 · Cited by 210 · see citing works
Alli, S. R., Gorbovskaya, I., Liu, J. C. W., Kolla, N. J., Brown, L., & Müller, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094494 · Cited by 202 · see citing works
Pellegrini, C., Antonioli, L., Calderone, V., Colucci, R., Fornai, M., & Blandizzi, C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101806 · Cited by 174 · see citing works
Microbiota-gut brain axis involvement in neuropsychiatric disorders
Iannone, L. F., Preda, A., Blottière, H. M., Clarke, G., Albani, D., Belcastro, V., Carotenuto, M., Cattaneo, A., Citraro, R., Ferraris, C., et al. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1638763 · Cited by 177 · see citing works
The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
Boddy, S. L., Giovannelli, I., Sassani, M., Cooper-Knock, J., Snyder, M. P., Segal, E., Elinav, E., Barker, L. A., Shaw, P. J., & McDermott, C. J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01885-3 · Cited by 127 · see citing works
Zhang, Z.-W., Gao, C.-S., Zhang, H., Yang, J., Wang, Y.-P., Pan, L.-B., Yu, H., He, C.-Y., Luo, H.-B., Zhao, Z.-X., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.032 · Cited by 139 · see citing works
Role of the intestinal microbiome, intestinal barrier and psychobiotics in depression
Trzeciak, P., & Herbet, M. (2021) · Nutrients · doi:10.3390/nu13030927 · Cited by 139 · see citing works
Gut microbes in neurocognitive and mental health disorders
Halverson, T., & Alagiakrishnan, K. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1808239 · Cited by 125 · see citing works
Can we ‘seize’ the gut microbiota to treat epilepsy?
De Caro, C., Iannone, L. F., Citraro, R., Striano, P., De Sarro, G., Constanti, A., Cryan, J. F., & Russo, E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.002 · Cited by 110 · see citing works
Nikolova, V., Cleare, A., Young, A., & Stone, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040647 · Cited by 106 · see citing works
Jiang, Y., Liu, Y., Gao, M., Xue, M., Wang, Z., & Liang, H. (2020) · Food & Function · doi:10.1039/c9fo01780a · Cited by 88 · see citing works
Kundu, P., Torres, E. R. S., Stagaman, K., Kasschau, K., Okhovat, M., Holden, S., Ward, S., Nevonen, K. A., Davis, B. A., Saito, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83851-4 · Cited by 75 · see citing works
Microbiota‐microglia connections in age‐related cognition decline
Zhou, R., Qian, S., Cho, W. C. S., Zhou, J., Jin, C., Zhong, Y., Wang, J., Zhang, X., Xu, Z., Tian, M., et al. (2022) · Aging Cell · doi:10.1111/acel.13599 · Cited by 71 · see citing works
Gut microbial changes of patients with psychotic and affective disorders: A systematic review
Vindegaard, N., Speyer, H., Nordentoft, M., Rasmussen, S., & Benros, M. E. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.014 · Cited by 66 · see citing works
Ford, A. L., Nagulesapillai, V., Piano, A., Auger, J., Girard, S.-A., Christman, M., Tompkins, T. A., & Dahl, W. J. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.12.009 · Cited by 63 · see citing works
Zhao, Z., Wang, B., Mu, L., Wang, H., Luo, J., Yang, Y., Yang, H., Li, M., Zhou, L., & Tao, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00258 · Cited by 57 · see citing works
Ou, Y., Belzer, C., Smidt, H., & de Weerth, C. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2038853 · Cited by 54 · see citing works
Suzuki, K., Nakamura, K., Shimizu, Y., Yokoi, Y., Ohira, S., Hagiwara, M., Wang, Y., Song, Y., Aizawa, T., & Ayabe, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89308-y · Cited by 50 · see citing works
Wasiak, J., & Gawlik-Kotelnicka, O. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114459 · Cited by 47 · see citing works
Lee, S. M., Dong, T. S., Krause-Sorio, B., Siddarth, P., Milillo, M. M., Lagishetty, V., Datta, T., Aguilar-Faustino, Y., Jacobs, J. P., & Lavretsky, H. (2022) · International Psychogeriatrics · doi:10.1017/s1041610221000120 · Cited by 43 · see citing works
Xie, X., Liao, J., Ai, Y., Gao, J., Zhao, J., Qu, F., Xu, C., Zhang, Z., Wen, W., Cui, H., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.748872 · Cited by 37 · see citing works
Perturbations in gut microbiota in autism spectrum disorder: a systematic review
Tao, X., Li, Z., Wang, D., Pu, J., Liu, Y., Gui, S., Zhong, X., Yang, D., Zhou, H., Tao, W., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1448478 · Cited by 23 · see citing works
Analysis of gut microbiota and depression and anxiety: Mendelian randomization from three datasets
Lai, Y., & Xiong, P. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.03.012 · Cited by 20 · see citing works
Cheng, H.-W., Jiang, S., & Hu, J. (2019) · Oral Health by Using Probiotic Products · doi:10.5772/intechopen.86775 · Cited by 17 · see citing works
- Authors
- Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E.
- Affiliations
- Columbia University (US)
- New York State Psychiatric Institute (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Sublette, M. Elizabeth
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2019-02-11
- Volume
- 10
- Pages
- 34-34
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC6378305
- OpenAlex
- W2912729292
- Cited by
- 597
- References
- 25
- Citations by year
- 2026: 44 · 2025: 75 · 2024: 93 · 2023: 90 · 2022: 96 · 2021: 95 · 2020: 77 · 2019: 25 · 2017: 1
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Nathaniel Wharton Fund
- National Institute of Mental Health (P50MH090964)
- National Institute of Allergy and Infectious Diseases (R01AI116939)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, major depressive disorder, gut-brain axis, bacterial taxa, Firmicutes, Lachnospiraceae, bacterial metabolism, etiology of depression, fecal microbiota, mental illness, Clostridium, Bifidobacterium, Faecalibacterium, Prevotella, Ruminococcus, Streptococcus, Blautia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review